to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
The U.S. Food and Drug Administration's laborious and lengthy approval process is hitting healthcare business owners in the pocketbook. But the FDA could be hitting consumers worse.
Medical device startups will be way ahead of their competitors if they know what to expect from the FDA approval process. Read more for tips on how to be prepared.
In this lecture, Mårten Mickos shares the benefits and challenges involved in building businesses in the open source and cloud computing spaces. As the CEO of Eucalyptus Systems, Mickos identifies a vision for the future of his industry and shares entrepreneurial lessons gained from leading MySQL AB from its startup origins to becoming one of the largest open source companies in the world.
Finally, the U.S. Food and Drug Administration is getting around to regulating mobile health applications. It's early in the game, but what do the new rules look like?
Federal regulations and overseas competition are just two of the barriers holding back medical device innovation, says one medical device industry executive. Read more about the other roadblocks to innovation.
Despite having a great product, your company can suffer from mistakes made during the product launch. Here are five tips on avoiding the mistakes others have made.
Academia is getting ever more aggressive about helping entrepreneurs get a running start. An emerging crown jewel could well be Stanford University's brand new StartX.
Many would agree that surgeons are qualified to create innovative medical devices that may be superior to what is currently available. But the controversy arises when surgeons begin to profit by purchasing their own products for use in their patients.
As the Co-Founder and CTO of Bespoke Innovations, Scott Summit leads a continuing effort to create products that radically change lives. In this lecture, Summit shares insights from creating customized prosthetic devices using new technologies in nascent markets. He also discusses some of the challenges his company faced in discovering a working business model and developing customers.
At this week's Biotech 2011 conference, speakers from Teva Pharmaceutical Industries and Merck spoke about how biotech companies can survive in this tough regulatory and economic environment.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.